Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncologist. 2014 Sep;19(9):1006-7. doi: 10.1634/theoncologist.2014-0054. Epub 2014 Aug 1.

Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.

Author information

  • 1Division of Oncology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • 2Institute of Pathology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • 3Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
  • 4Department of Nuclear Medicine, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
PMID:
25085898
PMCID:
PMC4153459
DOI:
10.1634/theoncologist.2014-0054
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center